Sign in
or
Join FriendFeed
FriendFeed
is the easiest way to share online.
Learn more »
Join FriendFeed
649
subscriptions
669
subscribers
7,767
comments
3,881
likes
Sally Church
Interested in Pharma, Biotech, Science and cancer... Find me at
http://www.pharmastrategyblog.com
also love food, wine, the NFL and cricket. Hi!
more »
« Newer items
Older items »
What’s hot at SABCS – Update 2 – advanced breast cancer -
http://pharmastrategyblog.com/2011...
December 10, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Follow the American Society of Hematology ASH conversations! -
http://pharmastrategyblog.com/2011...
December 10, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
What’s hot at the American Society of Hematology 2011? -
http://pharmastrategyblog.com/2011...
December 9, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
What’s hot at SABCS – Update 1 -
http://pharmastrategyblog.com/2011...
December 8, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Video preview of San Antonio Breast Cancer Symposium 2011 -
http://pharmastrategyblog.com/2011...
December 7, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Follow the conversation from 2011 San Antonio Breast Cancer Symposium -
http://pharmastrategyblog.com/2011...
December 6, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
EGFR activates mTORC2 in glioblastoma – a potential role for new therapies -
http://pharmastrategyblog.com/2011...
December 1, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Gone to dog drug heaven… -
http://pharmastrategyblog.com/2011...
November 29, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Exciting new approach to targeted therapy in prostate cancer -
http://pharmastrategyblog.com/2011...
November 28, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update from AACR Molecular Targets 2011 #2 – Angiogenesis -
http://pharmastrategyblog.com/2011...
November 22, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update from AACR Molecular Targets 2011 #1 – Breast Cancer -
http://pharmastrategyblog.com/2011...
November 21, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
AACR Molecular Targets Meeting -
http://pharmastrategyblog.com/2011...
November 12, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Epigenetics – an emerging new potential treatment for lung cancer? -
http://pharmastrategyblog.com/2011...
November 11, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on pancreatic Neuroendocrine Tumours (NET) -
http://pharmastrategyblog.com/2011...
November 10, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Redefining subsets of triple negative breast cancer -
http://pharmastrategyblog.com/2011...
November 9, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
How a metabolic protein PKM2 may have a key role in tumorigenesis -
http://pharmastrategyblog.com/2011...
November 8, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Excellent news in Advanced Prostate Cancer – Medivation’s MDV3100 meets primary endpoint -
http://pharmastrategyblog.com/2011...
November 3, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Understanding cancer metastasis – possible new therapeutic targets -
http://pharmastrategyblog.com/2011...
November 1, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
A year in the life of Pharma Strategy Blog -
http://pharmastrategyblog.com/2011...
October 31, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Beautiful -
http://pharmastrategyblog.com/2011...
October 31, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on EGFR resistance in lung cancer: new directions -
http://pharmastrategyblog.com/2011...
October 25, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on cabozantinib in medullary thyroid cancer -
http://pharmastrategyblog.com/2011...
October 24, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Useful resource on new therapies for lung cancer -
http://pharmastrategyblog.com/2011...
October 21, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
The elusive mystery of KRAS and EGFR inhibitors in colorectal cancer -
http://pharmastrategyblog.com/2011...
October 20, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Update on ADCs and immunotoxins in hematologic malignancies -
http://pharmastrategyblog.com/2011...
October 18, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Pharma Strategy Blog feed is back up -
http://pharmastrategyblog.com/2011...
October 17, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
When is NICE is not so nice? -
http://pharmastrategyblog.com/2011...
October 14, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Ovarian cancer patients with BRCA2 mutated tumors live longer -
http://pharmastrategyblog.com/2011...
October 12, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
Upcoming Fall cancer meetings -
http://pharmastrategyblog.com/2011...
October 11, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
On Science, Blogging and Drug Development -
http://pharmastrategyblog.com/2011...
October 10, 2011
from
Pharma Strategy Blog
-
Comment
-
Like
-
Share
« Newer items
Older items »
Other ways to read this feed: